Projeto
TARGETING TUMORS WITH INNOVATIVE METAL PEPTIDE COMPLEXAS: IMPROVING EFFICACY IN ANTICANCER DRUGS
| Referência: | SFRH/BPD/93513/2013 |
|---|---|
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade Politécnica de Lisboa |
Registos relacionados
Photoswitchable peptides as new antimicrobial and anticancer agents
Biophysical studies tounravel the mechanism of action of anticancer peptides
Targeting the proteasome in anticancer therapy by a computational based drug discovery approach
Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy
New advance in biomedicine: peptide-mediated target drug delivery
THERAPEUTIC ACTIVITY OF A TARGETED DRUG DELIVERY APPROACH ON TUMOR METASTASIZATION
Characterization and evaluation of therapeutic potential of anticancer and antibacterial peptides isolated from reptiles.
HIGH-THROUGHPUT CLONING OF VENOM PEPTIDES FOR DISCOVERY OF NOVEL THERAPEUTIC PEPTIDES AND INNOVATIVE DRUG DEVELOPMENT
Combining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor efficacy evaluation.
Targeting brain-resident viruses across the blood-brain barrier using peptide drugs.
Pharmacometabolomic response of anticancer drugs for personalized medicine in urological cancers
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
EXTRACÇÃO LÍQUIDO-LÍQUIDO NA SEPARAÇÃO DE METAIS RAROS E PRECIOSOS DE MATRIZES CLORETADAS COMPLEXAS
IMINOBORONATES AS USEFUL SCAFFOLDS FOR TUMOR-TARGETING
Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.
Poisoning the heart with anticancer drugs: is metabolic bioactivation or aging promotion the link to the cardiotoxicity of anticancer drugs New early putative biomarkers of cardiac damage for an earlier therapeutic approach
Targeting p53 family proteins: on the route to new anticancer agents
Targeting p53 family proteins: on the route to new anticancer agents
Trans-BBB peptides for targeting brain metastasis
Design of novel breast tumor ‘targeted` multifunctional nanoparticles
Amaryllidaceae-type alkaloids as anticancer hit/leads, targeting multidrug resistant cancer cells
Amaryllidaceae-type alkaloids as anticancer hit/leads, targeting multidrug resistant cancer cells
Novel approach to improve antifungal efficacy in pathogenic Candida species based on antisense therapy [2023.16872.ICDT]
alterado para: A precision medicine platform using patient derived cancer cell models to predict drug efficacy.
alterado para: A precision medicine platform using patient derived cancer cell models to predict drug efficacy.
Yeast as a tool to elucidate the anticancer activity of lactoferrin and its bioactive peptide lactoferricin [PD/BD/128032/2016]
MIR-143, -145 AND -21 MODULATION IN COLON CANCER - FROM ANTICANCER ACTIVITY TO DRUG SENSITIZATION
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Targeting superficial tumors using a nanotechnological hybrid approach
Innovative drugs targeting IDO molecular dynamics in autoimmunity and neoplasia [338954]
Thermal insulation solutions for historic buildings: feasibility, efficacy, compatibility.
Improving the efficiency and targeting of radiosensitisers
Marine Chemiluminescence as a Broad-Spectrum Anticancer Therapy with Enhanced Tumor-Selectivity and Activity [PTDC/QUI-QFI/2870/2020]
Metallodendrimers as HIV antiviral and anticancer agents.
ADDovenom: Novel Snakebite Therapy Platform of Unparalleled Efficacy, Safety and Affordability
Publicações relacionadas
Carregando publicações...